Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IrAE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06037811
What this trial is testing

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Who this might be right for
Inflammatory ArthritisImmune-related Adverse Event
Tom Appleton 30
Not applicableLooking for participantsNCT06461780
What this trial is testing

Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy

Who this might be right for
CancerImmunotherapyIrAE+4 more
Taipei Veterans General Hospital, Taiwan 200
Not applicableUnknownNCT05530187
What this trial is testing

EPRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Patient Reported Outcome MeasuresPatient Safety
Manuela Eicher 198
Not applicableNot Yet RecruitingNCT07756242
What this trial is testing

Pharmacokinetic Study of Therapeutic Plasma Exchange

Who this might be right for
Immune-related Adverse Event
University of Chicago 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303881
What this trial is testing

Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer

Who this might be right for
IrAEHematologic DisorderLung Cancer (Locally Advanced or Metastatic)
The First Affiliated Hospital of Guangzhou Medical University 16
Large-scale testing (Phase 3)Looking for participantsNCT06337695
What this trial is testing

Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With Cancer

Who this might be right for
IrAEImmune-related Adverse EventDiarrhea+1 more
AHS Cancer Control Alberta 36
Not applicableStudy completedNCT05544292
What this trial is testing

Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors

Who this might be right for
Immune-related Adverse Event
Diakonhjemmet Hospital 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07313202
What this trial is testing

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

Who this might be right for
Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE
Fujian Cancer Hospital 72
Not applicableStudy completedNCT04960059
What this trial is testing

NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

Who this might be right for
CancerMetastatic MelanomaRenal Cell Carcinoma+1 more
The Christie NHS Foundation Trust 24
Very early researchNot Yet RecruitingNCT06908018
What this trial is testing

Safety, Virological and Immunological Assessment of the Controlled Dengue Human Infection Model in Dengue-Immune Participants in Thailand (DHIT-Immune)

Who this might be right for
Safety IssuesDengueViremia+1 more
Mahidol University 12
Not applicableLooking for participantsNCT03989323
What this trial is testing

A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE

Who this might be right for
Cancer
Hospices Civils de Lyon 2,000
Not applicableLooking for participantsNCT06613165
What this trial is testing

Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

Who this might be right for
Immune-related Adverse EventNeoadjuvant TherapydMMR Colorectal Cancer
Xijing Hospital 100
Not applicableStudy completedNCT06440811
What this trial is testing

Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Immune-related Adverse EventChemotherapeutic ToxicityGastric or Gastroesophageal Junction Adenocarcinoma
Xijing Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06860542
What this trial is testing

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

Who this might be right for
PneumonitisImmune-related Adverse Event
AHS Cancer Control Alberta 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Post-approval studies (Phase 4)UnknownNCT06178146
What this trial is testing

Thymosin Alpha-1 for irAE Secondary to ICIs

Who this might be right for
IrAE
Jun Wang 40
Not applicableStudy completedNCT04513678
What this trial is testing

Development of ImmunOncoTool

Who this might be right for
CancerCancer, Treatment-Related
Northwestern University 64
Not applicableNot Yet RecruitingNCT07119190
What this trial is testing

A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Peking University People's Hospital 350
Not applicableLooking for participantsNCT06702566
What this trial is testing

The Effect of Serum Ferritin in irAE

Who this might be right for
Immune-related Adverse EventMalignant Solid TumorsAcute Leukemia+1 more
Tianjin Medical University Cancer Institute and Hospital 1,500
Post-approval studies (Phase 4)Not Yet RecruitingNCT06785974
What this trial is testing

Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis

Who this might be right for
AtherosclerosisMelanomaImmune-related Adverse Event
Erasmus Medical Center 140
Next Page